Prosurvival Kinase PIM2 Is a Therapeutic Target for Eradication of Chronic Myeloid Leukemia Stem Cells
Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1903550116
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 8, 2019
Authors
Publisher
Proceedings of the National Academy of Sciences